LobbyingCystic Fibrosis Foundation lobbying by quarter
Cystic Fibrosis Foundation's latest lobbying report covers Q2 2026, at $300K. The four quarters Q4 2025–Q3 2026 total $750K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Cystic Fibrosis Foundation
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $750K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $140K | 3 |
| Q1 2023 | $320K | 3 |
| Q2 2023 | $350K | 3 |
| Q3 2023 | $130K | 3 |
| Q4 2023 | $130K | 3 |
| Q1 2024 | $460K | 3 |
| Q2 2024 | $330K | 3 |
| Q3 2024 | $130K | 3 |
| Q4 2024 | $150K | 3 |
| Q1 2025 | $230K | 3 |
| Q2 2025 | $330K | 3 |
| Q3 2025 | $150K | 3 |
| Q4 2025 | $170K | 3 |
| Q1 2026 | $280K | 3 |
| Q2 2026 | $300K | 3 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$798.5K · 30 reports
- Medicare and Medicaid$771K · 29 reports
- Medical research and clinical labs$628.5K · 22 reports
- Budget and appropriations$581.8K · 15 reports
- Insurance$581.8K · 15 reports
- Government issues$126.7K · 4 reports
- Taxation$66.7K · 2 reports
- Pharmacy$45K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES33 reports
- SENATE33 reports
- Health & Human Services, Dept of (HHS)5 reports
- Centers For Medicare and Medicaid Services (CMS)4 reports
- Food & Drug Administration (FDA)4 reports
- White House Office3 reports
- Labor, Dept of (DOL)2 reports
- Treasury, Dept of2 reports
- Consumer Financial Protection Bureau (CFPB)1 reports
- Natl Institutes of Health (NIH)1 reports
- Office of Management & Budget (OMB)1 reports
- Office of Personnel Management (OPM)1 reports
- Social Security Administration (SSA)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseCystic Fibrosis Foundation | $3.1M | 15 quarters |
| Thorn Run Partners | $480K | 15 quarters |
| Turner & Goss | $0 | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CATHERINE FINLEY | Staff Director, Senate Special Aging Committee; Senior Health Policy Advisor, Sen. Smith; Legislative Asst, Sen. Snowe | Q2 2026 |
| SCOTT SHERWOOD | NONE | Q4 2025 |
| ASHLEIGH THARP | NONE | Q1 2024 |
| CASSIDY PELKEY | NONE | Q2 2023 |
| CHARLES WILLIAMS | REP.CAROLYN MALONEY: LEG. ASST. (3/20-9/22); SEN.SHERROD BROWN: LEG. CORRESPONDENT, SPECIAL ASST., STAFF ASST. (5/15-3/20) | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $270K |
| 07/20for Q2 | Thorn Run Partners | $30K |
| 07/19for Q2 | Turner & Goss | Under $5,000 |
| 04/20for Q1 | In-house | $250K |
| 04/19for Q1 | Turner & Goss | Under $5,000 |
| 04/18for Q1 | Thorn Run Partners | $30K |
| 01/20for Q4 2025 | In-house | $140K |
| 01/19for Q4 2025 | Thorn Run Partners | $30K |
| 01/19for Q4 2025 | Turner & Goss | Under $5,000 |
| 25/10/20for Q3 2025 | In-house | $120K |
| 25/10/20for Q3 2025 | Thorn Run Partners | $30K |
| 25/10/16for Q3 2025 | Turner & Goss | Under $5,000 |
| 25/07/21for Q2 2025 | In-house | $300K |
| 25/07/17for Q2 2025 | Turner & Goss | Under $5,000 |
| 25/07/16for Q2 2025 | Thorn Run Partners | $30K |
| 25/04/21for Q1 2025 | In-house | $200K |
| 25/04/17for Q1 2025 | Thorn Run Partners | $30K |
| 25/04/16for Q1 2025 | Turner & Goss | Under $5,000 |
| 25/01/21for Q4 2024 | In-house | $120K |
| 25/01/20for Q4 2024 | Turner & Goss | Under $5,000 |